<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02442596</url>
  </required_header>
  <id_info>
    <org_study_id>ABSES</org_study_id>
    <nct_id>NCT02442596</nct_id>
  </id_info>
  <brief_title>Abdominal SepsiS Study: Epidemiology of Etiology and Outcome</brief_title>
  <acronym>AbSeS</acronym>
  <official_title>Abdominal SepsiS Study: Epidemiology of Etiology and Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Society of Intensive Care Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Society of Intensive Care Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to perform a multinational, prospective, observational study on
      IAIs (IntraAbdominal Infections) in critically ill patients; special emphasis will be given
      to epidemiology and outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate microbiology and/or drug resistance patterns related to: Geographical region,
      Source of IAI, Upper GI tract perforation (stomach &amp; duodenum), Lower GI tract perforation
      (jejunum, ileum, colon, rectum), Primary peritonitis, Peritoneal dialysis-related
      peritonitis, Intra-abdominal abscess, Pancreatic infection, Biliary tract infection,
      Typhlitis, Toxic megacolon.

      To check the Origin of IAI: community-acquired, early-onset healthcare-associated, late-onset
      healthcare-associated.

      To describe physician's antimicrobial prescription patterns related to a classification grid
      that stratifies IAIs according to disease expression, community or healthcare origin, and
      anatomical disruption.

      To investigate outcomes (clinical response, need for surgical revision, length of
      hospitalization, and mortality) related to: Classification of IAI, Severity of acute illness
      at time of diagnosis (SOFA score) and clinical response after 48-72 hrs. (SOFA score),
      Processes of care (Time to 1st antimicrobial dose, Time to source control, Type of source
      control intervention (laparotomy, percutaneous drainage, high volume peritoneal lavage,
      restoration of anatomy and function), Need for (unplanned) surgical revision (uncontrolled
      infection source), Frequency of microbiological sampling and delay of results)), Pathogens
      involved and empirical antimicrobial coverage; special emphasis will be given, to coverage of
      multidrug resistant Enterobacteriaceae, Pseudomonas aeruginosa, enterococci and Candida
      species, Duration of antimicrobial therapy, Underlying conditions
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">April 2, 2017</completion_date>
  <primary_completion_date type="Actual">April 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical response</measure>
    <time_frame>Clinical response at 3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical response</measure>
    <time_frame>Clinical response at 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical revision</measure>
    <time_frame>within the first week</time_frame>
    <description>For the abdominal sepsis cases that were managed with a surgical intervention (most of them), the need for a surgical revision (re-intervention) within the first week after the initial procedure is considered &quot;failure of initial source control&quot;. The need for an additional surgical intervention within the first week will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Length of ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>During the 6 month study period</time_frame>
    <description>Survival status at discharge</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2200</enrollment>
  <condition>Intra-Abdominal Infections</condition>
  <arm_group>
    <arm_group_label>One Group</arm_group_label>
    <description>This is a prospective observational study, aimed at collecting an adequate dataset on a large cohort of patients admitted to a large number of ICUs.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive, adult ICU patients diagnosed with IAI- intra-abdominal infection (either
        as a primary diagnosis or as a complication during the ICU course) during a 6 months period
        and with a maximum of 15 cases per unit.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (≥18 yrs. of age)

          -  IAI treated with percutaneous or surgical procedure

          -  ICU admission (the patient should either be admitted to the ICU because of abdominal
             sepsis or should be admitted in the ICU for other reasons and subsequently developed
             abdominal sepsis as a complication during the ICU course)

          -  Informed consent (if required by local ethics committee)

        Exclusion Criteria:

        &lt;18 yrs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stijn BLOT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ghent, Dept. of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dirk VOGELAERS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ghent, Dept. of Internal Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>All Centres From All Over the World Willing to Contribute Are Welcome</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Marshall JC. Intra-abdominal infections. Microbes Infect. 2004 Sep;6(11):1015-25. Review.</citation>
    <PMID>15345234</PMID>
  </reference>
  <reference>
    <citation>De Waele JJ. Early source control in sepsis. Langenbecks Arch Surg. 2010 Jun;395(5):489-94. doi: 10.1007/s00423-010-0650-1. Epub 2010 Jun 2. Review.</citation>
    <PMID>20517699</PMID>
  </reference>
  <reference>
    <citation>Schein M, Marshall J. Source control for surgical infections. World J Surg. 2004 Jul;28(7):638-45. Epub 2004 Jun 8. Review.</citation>
    <PMID>15185005</PMID>
  </reference>
  <reference>
    <citation>Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65(12):1611-20. Review.</citation>
    <PMID>16060697</PMID>
  </reference>
  <reference>
    <citation>Rex JH. Candida in the peritoneum: passenger or pathogen? Crit Care Med. 2006 Mar;34(3):902-3.</citation>
    <PMID>16505676</PMID>
  </reference>
  <reference>
    <citation>de Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009 Dec;37(6):522-7. doi: 10.1007/s15010-009-8249-6.</citation>
    <PMID>19669089</PMID>
  </reference>
  <reference>
    <citation>Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, Chong TW, Popovsky KA, Pruett TL, Sawyer RG. Choosing antibiotics for intra-abdominal infections: what do we mean by &quot;high risk&quot;? Surg Infect (Larchmt). 2009 Feb;10(1):29-39. doi: 10.1089/sur.2007.041.</citation>
    <PMID>19226202</PMID>
  </reference>
  <reference>
    <citation>Dupont H, Friggeri A, Touzeau J, Airapetian N, Tinturier F, Lobjoie E, Lorne E, Hijazi M, Régimbeau JM, Mahjoub Y. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011 Oct;66(10):2379-85. doi: 10.1093/jac/dkr308. Epub 2011 Jul 25.</citation>
    <PMID>21791444</PMID>
  </reference>
  <reference>
    <citation>Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009 Apr;63(4):785-94. doi: 10.1093/jac/dkp005. Epub 2009 Feb 5.</citation>
    <PMID>19196742</PMID>
  </reference>
  <reference>
    <citation>Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012 Apr 16;72(6):e17-32. doi: 10.2165/11599800-000000000-00000.</citation>
    <PMID>22480338</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2015</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abdominal sepsis</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Septic shock</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Etiology</keyword>
  <keyword>Microbiology</keyword>
  <keyword>Abdomen</keyword>
  <keyword>Intra-abdominal</keyword>
  <keyword>Infection</keyword>
  <keyword>Gastrointestinal tract</keyword>
  <keyword>Perforation</keyword>
  <keyword>Peritonitis</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Biliary tract</keyword>
  <keyword>Megacolon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Intraabdominal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

